Delivery Order SPE2DR25D1202-SPE2DR26F73HH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,473.88 by the Defense Logistics Agency on December 8, 2025, for the supply of Zilretta 32 mg vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 30, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,631.84 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing at its corporate office location in the same city and serves as a critical pharmaceutical distributor for federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency has awarded a delivery order valued at $4,457.88 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zilretta 32 mg vials, with a ceiling value of $1,438.64. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,228.94 by the Defense Logistics Agency on June 16, 2025, for the supply of Zilretta 32 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 9, 2025, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zilretta 32 mg vials, a corticosteroid injection used for osteoarthritis pain management. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,438.60 and is scheduled for completion by December 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,596.60 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials on December 4, 2025, with an ultimate completion date of December 26, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing one...
- The Defense Logistics Agency awarded a $17,831.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 17, 2025. This non-set-aside contract was competitively awarded on September 25, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73HHDelivery Order
The Defense Logistics Agency awarded a $34,526.40 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio primarily with the Defense Logistics Agency, supplying an extensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. Zilretta is an intra-articular injection used for post-operative pain management, reflecting the contractor's role in providing specialized medications across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal medical procurement requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 12/18/25 |